Alejandro Balsa Selected Research

Uric Acid (Urate)

9/2017

Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Balsa Research Topics

Disease

97	Rheumatoid Arthritis 02/2024 - 04/2003
11	Inflammation (Inflammations) 01/2021 - 07/2004
10	Necrosis 02/2024 - 12/2012
9	Arthritis (Polyarthritis) 03/2022 - 05/2007
7	Rheumatic Diseases (Rheumatism) 01/2024 - 09/2011
7	Axial Spondyloarthritis 01/2023 - 01/2016
6	Atherosclerosis 01/2016 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2011
4	Infections 08/2023 - 02/2009
4	Ankylosing Spondylitis 01/2022 - 07/2013
4	Psoriatic Arthritis 01/2020 - 08/2017
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2005
3	Obesity 01/2023 - 09/2022
2	Overweight 01/2023 - 01/2019
2	Neoplasms (Cancer) 01/2023 - 08/2012
2	Disease Progression 12/2020 - 01/2015
2	Multiple Sclerosis 01/2018 - 09/2007
2	Dyslipidemias (Dyslipidemia) 01/2017 - 08/2012
2	Autoimmune Diseases (Autoimmune Disease) 09/2007 - 01/2007
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2007 - 12/2006
1	Body Weight (Weight, Body) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021
1	Posterior Uveitis 09/2019
1	Uveitis 09/2019
1	Anterior Uveitis 09/2019
1	Osteoporosis 03/2019
1	Human Influenza (Influenza) 03/2019
1	Gout 09/2017
1	Non-Radiographic Axial Spondyloarthritis 08/2017
1	Ulcerative Colitis 08/2017

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor InhibitorsIBA 02/2024 - 12/2007
16	AntibodiesIBA 01/2024 - 05/2007
14	Infliximab (Remicade)FDA Link 01/2024 - 04/2004
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2012
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2007
12	Antirheumatic Agents (DMARD)IBA 01/2023 - 04/2003
9	Anti-Citrullinated Protein AntibodiesIBA 11/2020 - 05/2010
8	Rheumatoid FactorIBA 02/2024 - 09/2009
8	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 07/2004
7	AutoantibodiesIBA 01/2023 - 04/2015
7	CytokinesIBA 01/2023 - 07/2004
7	Adalimumab (Humira)FDA Link 01/2023 - 03/2015
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2010
5	Rituximab (Mabthera)FDA Link 08/2023 - 01/2011
5	tocilizumab (atlizumab)FDA Link 01/2023 - 09/2015
5	Interleukin-15 (Interleukin 15)IBA 12/2009 - 07/2004
4	Abatacept (Orencia)FDA Link 02/2024 - 01/2013
4	baricitinibIBA 01/2023 - 01/2019
4	golimumab FDA Link 01/2023 - 01/2018
4	Etanercept (Enbrel)FDA Link 01/2023 - 01/2014
4	cyclic citrullinated peptideIBA 01/2021 - 09/2009
3	Certolizumab Pegol FDA Link 02/2024 - 01/2020
3	Janus Kinase InhibitorsIBA 12/2023 - 01/2020
3	GLPG0634IBA 12/2023 - 01/2020
3	Biosimilar PharmaceuticalsIBA 01/2023 - 08/2017
3	C-Reactive ProteinIBA 01/2022 - 02/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2014
3	Peptides (Polypeptides)IBA 03/2015 - 05/2007
3	EpitopesIBA 01/2015 - 09/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 07/2004
2	Immunomodulating AgentsIBA 08/2023 - 09/2019
2	sarilumabIBA 01/2023 - 01/2020
2	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 01/2020
2	tofacitinibIBA 01/2023 - 01/2020
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 01/2020
2	AdipokinesIBA 01/2023 - 09/2022
2	upadacitinibIBA 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 03/2022 - 03/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2019 - 02/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2016
2	acetyl 4-aminosalicylic acidIBA 08/2016 - 03/2015
2	OsteopontinIBA 03/2015 - 03/2005
2	Genetic Markers (Genetic Marker)IBA 01/2015 - 01/2014
2	Interferon Regulatory FactorsIBA 07/2014 - 01/2011
2	Monoclonal AntibodiesIBA 12/2012 - 09/2004
2	Messenger RNA (mRNA)IBA 10/2012 - 12/2006
2	NF-kappa B (NF-kB)IBA 01/2009 - 10/2007
1	ProteomeIBA 01/2024
1	Prostaglandins AIBA 01/2023
1	AdiponectinIBA 01/2023
1	N-phthaloylglutamic acidIBA 01/2023
1	Interleukin-6 InhibitorsIBA 01/2023
1	LeptinIBA 01/2023
1	B-Cell Activating FactorIBA 09/2022
1	Immunoglobulin A (IgA)IBA 03/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	OrnithineIBA 11/2020
1	Janus KinasesIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2019
1	SteroidsIBA 09/2019
1	Vitamin D FDA LinkGeneric 03/2019
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Uric Acid (Urate)IBA 09/2017

Therapy/Procedure

18	Therapeutics 01/2024 - 04/2004
13	Biological Therapy 12/2023 - 09/2011
1	Polypharmacy 11/2022
1	Drug Tapering 12/2019